Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7998980 Compounds for modulating TRPV3 function

Patent 7998980 was granted and assigned to Hydra Biosciences on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Hydra Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7998980

Patent Inventor Names

Xiaoguang Zhen0

Jayhong A. Chong0

Magdalene M. Moran0

Manfred Weigele0

Amy Ripka0

Christopher Fanger0

Dennis John Underwood0

Glenn R. Larsen0

Date of Patent

August 16, 2011

Patent Application Number

11901253

Date Filed

September 14, 2007

Patent Primary Examiner

‌

Margaret D. Seaman

Patent abstract

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7998980 Compounds for modulating TRPV3 function

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API